Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TKPHF - Takeda Pharmaceutical: Eohilia's FDA Approval Brings Tailwinds

TKPHF - Takeda Pharmaceutical: Eohilia's FDA Approval Brings Tailwinds

Takeda Pharmaceutical Co Ltd

2024-03-05 09:54:23 ET

Summary

  • Takeda wins FDA approval for the first oral treatment for Eosinophilic esophagitis (EoE) in the US.
  • The market size for EoE is expected to reach $941.8 million by 2031.
  • Takeda's new CFO, Milano Furuta, will focus on growth and increasing shareholder returns.

Editor's note: Seeking Alpha is proud to welcome BioCGT Investor as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Premium. Click here to find out more » ...

For further details see:

Takeda Pharmaceutical: Eohilia's FDA Approval Brings Tailwinds
Stock Information
Company Name: Takeda Pharmaceutical Co Ltd
Stock Symbol: TKPHF
Market: OTC
Website: takeda.com
Menu
TKPHF TKPHF Quote TKPHF Short TKPHF News TKPHF Articles TKPHF Message Board
Get TKPHF Alerts

News, Short Squeeze, Breakout and More Instantly...